[18F]FMISO-PET with contrast-enhanced MRI

DRUG2 trials

Sponsors

University of Alabama at Birmingham

Conditions

GliomaTriple Negative Breast Cancer

Early Phase 1

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

RecruitingNCT04861077

University of Alabama at BirminghamTriple Negative Breast Cancer

Start: 2027-06-01End: 2030-08-01Target: 20Updated: 2026-08-17

Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas

Not yet recruitingNCT07778979

University of Alabama at BirminghamGlioma

Start: 2026-09-01End: 2030-11-01Target: 20Updated: 2026-08-24